superoxide dismutase
superoxide dismutase
Overview
Superoxide dismutase (SOD) is a family of metalloenzymes that serves as a primary enzymatic antioxidant defense in virtually all aerobic organisms. SOD catalyzes the dismutation of the superoxide radical anion (O₂•⁻) into molecular oxygen and hydrogen peroxide, which is subsequently neutralized by catalase or glutathione peroxidase. Three major isoforms exist in mammals: the cytoplasmic copper/zinc-containing SOD1, the mitochondrial manganese-containing SOD2, and the extracellular SOD3. By controlling superoxide levels, SOD plays an indispensable role in maintaining redox homeostasis, protecting cellular membranes, proteins, and nucleic acids from oxidative damage. Its activity is routinely used as a surrogate biomarker of the overall antioxidant capacity of tissues and biological fluids.
Beyond its canonical enzymatic role, SOD activity has been co-opted in biomedical engineering as the conceptual template for a broad class of synthetic antioxidant nanomaterials known as nanozymes—nanostructured materials that mimic SOD's catalytic mechanism. The enzyme functions in concert with catalase (CAT), glutathione peroxidase (GPx), and non-enzymatic antioxidants such as glutathione to constitute a tiered, integrated defense against reactive oxygen species (ROS). Dysregulation of SOD activity is implicated in a wide spectrum of pathologies including diabetes mellitus, neurodegeneration, sepsis-associated organ injury, cardiovascular disease, and chronic inflammatory disorders, making it a critical molecular target in translational research.
Focus of Latest Publications
Recent publications have examined superoxide dismutase (SOD) primarily as part of oxidative-stress–modulating strategies across diverse disease and biomaterial contexts. Several studies evaluated interventions with SOD-mimicking or SOD-related activity, including cerium oxide nanozymes for cataract, catechol-zinc nano-enzymes in an amylase-responsive oral ulcer film, hollow MnO2 nanozymes in an injectable hydrogel for intrauterine adhesion, and an all-natural hydrogel with GAO/CAT-mediated redox modulation. In these settings, SOD activity was linked to reactive oxygen species scavenging, often alongside catalase-like effects, to support tissue protection and repair.
In ophthalmic and reproductive tissue models, SOD-mimetic systems were reported to reduce oxidative injury and improve outcomes. Cerium oxide nanozymes were described as mimicking SOD and catalase through a Ce3+/Ce4+ redox cycle, with repeatable ROS scavenging in vitro and reduced lens turbidity, improved lens fiber integrity, and decreased apoptosis in UV-induced rat cataracts. Similarly, MnO2@E2 nanoparticles in a hyaluronic acid hydrogel showed SOD-like and catalase-like activity, scavenged ROS, protected human endometrial stromal cells, and promoted endometrial repair in a rat injury model. The GAO/CAT-integrated hydrogel was also reported to exhibit SOD-like activity and, together with catalase, to scavenge ROS/RNS in human osteoarthritis synovial fluid, supporting cartilage regeneration in mice.
Other studies used SOD as a biomarker or mechanistic readout of oxidative balance. In monozygotic twins discordant for pain-related temporomandibular disorder, plasma SOD was measured alongside inflammatory and matrix-remodeling markers, and painful TMD was associated with altered oxidative indices, including the MDA/SOD ratio. In hypertension-related functional bread studies, increased SOD activity accompanied reduced reactive oxygen species and malondialdehyde levels, consistent with improved antioxidant defense. In a cognitive dysfunction study in diabetic rats, empagliflozin and dapagliflozin were assessed in silico against SOD among other targets, and both drugs increased brain SOD levels in vivo while improving behavioral performance.
A separate antibacterial study also implicated SOD inhibition as part of a pro-oxidant antimicrobial mechanism. A garlic-derived disulfide compound was reported to inhibit both catalase and SOD activities in Erwinia amylovora, causing lethal ROS accumulation, cell envelope damage, and reduced virulence. Overall, these recent publications position SOD as a recurring node in oxidative-stress regulation, either as a therapeutic mimic to enhance ROS clearance or as a target whose inhibition contributes to antimicrobial activity.